Large screening efforts using small interfering RNAs identified RPS6KA3 (encoding RSK2) as being absolutely required to sustain the growth of estrogen-receptor negative breast cancer suggesting it may be a relevant target [6, 7]. Here, RPS6KA3 is linked to estrogen-receptor negative breast cancer.